Peer-reviewedCC BY-NC-ND 4.0Signal Transduction and Targeted Therapy9 Nov 2026

Mutant KRAS vaccination for pancreatic cancer interception: the G12D immunogenicity paradox

Morten Orebo Holmström^1,2
Mie Linder Hübbe¹
Inna Markovna Chen³
Mads Hald Andersen^1,2

¹Department of Oncology, National Center for Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, Herlev, Denmark
²Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
³Department of Oncology, Copenhagen University Hospital, Herlev, Denmark

First-in-Human Testing of a Mutant KRAS Vaccine for Pancreatic Cancer Interception in High-risk Cohorts
Saurav Daniel Haldar, Amanda L. Huff, Hejia Henry Wang +25
Cancer Discovery16 Jul 2026Peer-reviewedLicence not statedFull text12 citedOncologyOpenAlex
Immunogenicity and safety of an interchangeable vaccination schedule of two inactivated Japanese encephalitis vaccines: a multicentric, phase IV, open-label, randomized controlled trial
Jeromie Wesley Vivian Thangaraj, Himabindu Reddy, Gajanan N. Sapkal +33
EClinicalMedicine22 Sep 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Early detection and interception in hepato-pancreatic-biliary cancers: endoscopic imaging, liquid biopsy, and emerging molecular biomarkers
Mohamed Aseafan, Ahmed Alqayidi, Saqer Dayis +2
Frontiers in Oncology2 Nov 2026Peer-reviewedCC BY 4.0OncologyFrontiersCrossref
The vaccination paradox: how East Africa’s success in Ebola vaccine preparedness may be creating new public expectations for future outbreaks
Okechukwu Paul-Chima Ugwu, Chinyere Nneoma Ugwu, Godson Emeka Anyanwu +2
Frontiers in public health2 Oct 2026Peer-reviewedCC BYFull textInfectious diseaseEurope PMCCrossref
Immunogenicity of sequential conjugate and non-conjugate pneumococcal vaccination in dialysis patients and kidney transplant recipients: a 12-month serological follow-up
Sophie Novelli, Aimé Nun, Antoine Cases +3
Frontiers in Immunology8 Oct 2026Peer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMC

Cite

BibTeX

@article{holmstrom2026mutant,
  title = {{Mutant KRAS vaccination for pancreatic cancer interception: the G12D immunogenicity paradox}},
  author = {Morten Orebo Holmström and Mie Linder Hübbe and Inna Markovna Chen and Mads Hald Andersen},
  journal = {Signal Transduction and Targeted Therapy},
  year = {2026},
  month = nov,
  doi = {10.1038/s41392-026-03088-3},
  url = {https://doi.org/10.1038/s41392-026-03088-3},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Mutant KRAS vaccination for pancreatic cancer interception: the G12D immunogenicity paradox
AU  - Morten Orebo Holmström
AU  - Mie Linder Hübbe
AU  - Inna Markovna Chen
AU  - Mads Hald Andersen
PY  - 2026
DA  - 2026/11/09
JO  - Signal Transduction and Targeted Therapy
DO  - 10.1038/s41392-026-03088-3
UR  - https://doi.org/10.1038/s41392-026-03088-3
SN  - 2095-9907
SN  - 2059-3635
ER  -

Related

Cite